New drug combo shrinks tumors in most patients facing aggressive cancer type
The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, and 8.2% saw tumors vanish on scans.
Covered by 1 source ·
Every side
-
Fox News
The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, and 8.2% saw tumors vanish on scans.